H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act

About This Bill

Bill Sponsor

Bill Cosponsors

2 (1 Democrat, 1 Republican)

Bill Version

Bill Summary

Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act This bill limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell a biosimilar version of that drug. (A biologic drug is produced through natural processes or isolated from natural sources. A biosimilar version is substantially similar to the original biologic, which is...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 3 statements associated with H.R.2884.

Bill Actions

Date Description
Sept. 30, 2021
Ordered to be Reported in the Nature of a Substitute by Voice Vote.
Sept. 30, 2021
Committee Consideration and Mark-up Session Held.
April 28, 2021
Referred to the House Committee on the Judiciary.
April 28, 2021

Introduced in the House by Hank Johnson (D-Ga.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page